Despite consistent observations of sex differences in depression and related emotional disorders, we do not yet know how these sex differences modulate the effects of genetic polymorphisms implicated in risk for these disorders. This Mini-Review focuses on genetic polymorphisms of the serotonergic system to illustrate how sex differences might modulate the neurobiological pathways involved in the development of depression. We consider the interacting role of environmental factors such as early-life stress. Given limited current knowledge about this topic, we highlight methodological considerations, challenges, and guidelines for future research. V C 2016 Wiley Periodicals, Inc.
and Gorman, 2001) , and 43% (McGuffin et al., 2010) , respectively. Single gene variations involved in serotonergic metabolism in particular have been extensively studied for their role in depression. However, these single gene variations may confer depression risk through interactions with environmental factors rather than via their own discrete effects, and these gene-environment interactions may themselves be mediated by sexually dimorphic pathways.
Epidemiological studies have long highlighted sex differences in depression and its related phenomenology. Women have a 21.3% lifetime rate of depression compared with 12.7% for men (Kessler et al., 1993) . Similarly, women have a higher lifetime rate of generalized anxiety disorder of 7.7% compared with 4.1% for men as well as higher comorbidity with depression, 38.3% for women compared with 30% for men (McLean et al., 2011) . However, the suicide rate for depressed men is 7% compared with 1% for depressed women (Blair-West et al., 1999) . Heritability of major depression is higher in women (42%) than in men (29%), which suggests modulation of genetic risk by sex (Kendler et al., 2006) . Sex differences have also been observed in environmental risk factors, such as early-life stress (Bale and Epperson, 2015) , and in biobehavioral factors implicated in the mechanisms by which risk for depression is conferred, including personality traits such as neuroticism (Goodwin and Gotlib, 2004 ) and brain measures such as amygdala reactivity . This Mini-Review focuses on the current state of knowledge with regard to sex differences in genetic variation implicated in risk for depression and related phenomena.
SCOPE OF THIS MINI-REVIEW
Our intention is to provide a focused review and personal view highlighting the potential mechanisms for how sex differences might modulate the effect of genetic polymorphisms in depression and its related conditions (i.e., genesex interactions) rather than a systematic review of genesex interactions. We hope to show the importance of considering sex differences, even when studying the brain at the genetic level.
This Mini-Review focuses on major depressive disorder, also including evidence with regard to anxiety and externalizing disorders that are highly comorbid with depression (Hirschfeld, 2001) and with regard to suicidality, given its association with depression (Blair-West et al., 1999) . Although we focus on the serotonergic system, we do not intend to imply that it is the only system for which gene-sex interactions are relevant to depression and related phenomena. Rather, we hope this focused Mini-Review will serve as a template for considering sex differences in other biological genetic pathways implicated in depression.
We propose three potential pathways through which polymorphisms in genes involved in serotonin synthesis, transport, and breakdown may differentially impact behavior as a function of sex. First, we consider sex differences in response to early-life stress and the effects of stress on gene-sex interactions involving the serotonin transporter-linked polymorphic region (5-HTTLPR) in the serotonin transporter gene (SLC6A4), which codes for the protein that transports serotonin from the synaptic cleft to the presynaptic neuron. Next, we consider the effects of X-linkage, using as an example the monoamine oxidase-A-linked polymorphic region (MAOA-LPR), which alters the degradation serotonin and other amine neurotransmitters. Third, we consider how sex hormones interact with gene products, focusing on polymorphisms in two tryptophan hydroxylase (TPH) isozymes, TPH1 and TPH2, the rate-limiting enzymes in serotonin biosynthesis in the periphery and central nervous system (Zhang et al., 2004) . We do not intend to suggest that these are the only pathways through which gene-sex interactions exert their effect within the serotonergic system or that genetic polymorphisms are modulated only by these pathways. Rather, our intention is to illustrate the central role of sex in the biobehavioral effects of polymorphisms involved in the serotonergic system.
For each polymorphism, we summarize findings of association with depression, its related disorders (anxiety disorders, conduct disorder, and suicide), trait risk factors (neuroticism, harm avoidance, aggression, and impulsiveness), and neurobiological endophenotypes, including amygdala hyperactivation, limbic structure and function, and affective processing (see Tables I-III) . For all polymorphisms, we include studies with significant gene main effects or significant gene-environment interactions in one or both sexes. We classified a finding as showing a sex difference when 1) an allele conferred opposite risk in men and women, 2) significant main effects emerged only for one sex, or 3) differing interaction effects emerged. We classified a finding as having no sex difference only when the investigators explicitly tested for and ruled out a sex interaction. Studies were classified as having unclear gene-sex interactions when 1) only one sex was studied, 2) sex interactions were not tested in a mixed group, 3) marginally significant sex differences were found, or 4) sex differences were found in measures not included in the table. Because of space constraints, we limit the listing of the studies performed on the association between 5-HTTLPR and depression to those focusing solely on sex differences. A more complete listing may be found in Karg et al. (2011) and Sharpley et al. (2014) . We chose to include studies performed on only one sex because the risk directionality of some of the alleles may be sex dependent. For example, although the preponderance of studies indicate that MAOA-L confers risk for conduct disorder in boys, the female-only study performed by Sj€ oberg et al. (2007) supports the hypothesis that the other allele, MAOA-H, confers risk in girls. However, additional studies performed with both sexes are essential to confirm these associations. Studies that show gene-sex interactions are listed in Table IV along with sample and effect sizes. The Mini-Review concludes by highlighting the conceptual and methodological difficulties of studying gene-sex interactions and suggesting directions for future research 
DEPRESSION AND RELATED CONDITIONS
Existing diagnostic categories of clinical depression and related disorders, currently defined by symptom criteria, may in fact comprise an ensemble of multiple underlying dysfunctions that are more cohesive when defined by neurobiobehavioral measures (Williams, 2016) . These underlying neurobiobehavioral dysfunctions may not map to symptom-based boundaries, but they define consistent subtypes that are present across different diagnoses. Sex differences may be an important consideration for anchoring a neurobiobehavioral understanding of depression. For example, women have been reported to have a tendency to internalize distress, whereas men have been reported to have a tendency to externalize distress (Eaton et al., 2012) . Internalizing might reflect the action of particular biobehavioral mechanisms for depressed or anxious outcomes in women, and externalizing might reflect the action of different mechanisms for antisocial or aggressive outcomes in men; investigation of sex differences could help to disentangle the pathways of genetic risk for clinical expressions of depression and emotional dysregulation. This Mini-Review considers these clinical expressions as including depression, anxiety, conduct disorders, and suicidality.
Another collection of depression-related phenomena may be considered "latent expressions" of risk for overt clinical states; these include personality traits as well as alterations in brain anatomy and functional activity. The personality trait of neuroticism in the Revised NEO Personality Inventory, reflecting a dispositional bias toward negative information, is higher in women than in men across 26 cultures, with U.S. women scoring 0.51 SD higher than their male counterparts (Costa et al., 2001) . These higher levels of neuroticism are thought to be a latent trait that moderates the expression of a greater prevalence of depression in females (Goodwin and Gotlib, 2004) . Similarly, trait harm avoidance is associated with panic disorder and general anxiety (Starcevic et al., 1996) , and trait impulsiveness, which is thought to be reflective of low serotonin turnover, is associated with suicide (Fawcett et al., 1997) . Likewise, structural and functional alterations of the brain are subject to sex differences that exist on the spectrum of subclinical to healthy brains. Dysfunctional activity in the amygdala and other limbic structures correlates with depression severity, probability of relapse, and dysregulated processing of emotionally valenced stimuli, which may reflect a trait risk for depression (for review see Drevets, 2000) . Healthy women exhibit more persistent amygdala activity in response to fear signals than men . With regard to neuroanatomy, decreased hippocampal volume, which is thought to reflect the effects of chronic stress, has been observed in both male and female depressed patients (Videbech and Ravnkilde, 2004) , although hippocampal size and microstructure are altered in men but not women with subclinical depression .
THE SEROTONIN SYSTEM IN MEN AND
WOMEN This Mini-Review focuses on the serotonergic system because it 1) plays an important role in mood and mood disorders, 2) is widely accepted to be sexually dimorphic, 3) encompasses polymorphisms that have been extensively studied with respect to mood disorders, and 4) is directly relevant to the efficacy of selective serotonin reuptake inhibitors (SSRIs), the most commonly used treatments for depression and anxiety, making it an important aspect of individualized treatment and precision medicine. Apart from its role as a neurotransmitter, serotonin also plays a role in brain development by regulating neurite outgrowth, synaptogenesis, and cell survival (Gaspar et al., 2003) , all of which have important consequences for neurobiological function.
Sexual dimorphisms within the serotonin system have been known for the past 4 decades. Males and females exhibit different rates of serotonin synthesis (Nishizawa et al., 1997) , different levels of serotonin metabolites (Gottfries et al., 1974) , different receptor and transporter binding potentials (Jovanovic et al., 2008) , and different SSRI response and tolerance (Kornstein et al., 2000) . Furthermore, acute tryptophan depletion, which induces lower mood in recovered depressed patients by temporarily decreasing serotonin levels, leads to larger mood-lowering effects in women than in men (Booji et al., 2002) .
Sex differences within the serotonergic system might, on their own, account for some of the sex differences in genetic risk for depression and related clinically expressed phenomena. In addition, sex differences multiply when serotonergic gene products interact with, regulate, and are modulated by other sexually dimorphic biological pathways. This Mini-Review discusses the interface of serotonergic genetic polymorphisms with three such pathways, the effects of early-life stress, the effects of sex chromosome differences, and the effects of sex hormones.
POTENTIAL PATHWAYS OF SEX MODULATION OF GENETIC POLYMORPHISMS Mechanism: Early-Life Stress
Exposure to early-life stress is a risk factor for developing mood and anxiety disorders, partially because of long-term stress response dysregulation, cognitive coping strategies, and neurobiological anatomy (Heim and Nemeroff, 2001 ). Many genes that have been implicated in depression, including brain-derived neurotrophic factor (BDNF), catechol-O-methyltransferase, and corticotropin-releasing hormone receptor 1, have more pronounced effects in the context of early-life stress (Heim and Binder, 2012) . No sex difference: Denotes studies in which gene-sex interactions were not found Sex difference: Denotes studies in which ( †) significant effects emerged for only one sex, ( ‡) significant effects emerged in opposite directions by sex, or interaction effects were different.
Did not examine/Unclear: Denotes studies in which (1) only one sex was studied, (2) sex interactions were not ruled out, (3) marginally significant sex differences were found, or (4) sex differences were found in measures not included in the Bold Underlining denotes studies that observed sex differences. No sex difference: Denotes studies in which gene-sex interactions were not found Sex difference: Denotes studies in which ( †) significant effects emerged for only one sex, ( ‡) significant effects emerged in opposite directions by sex, or interaction effects were different.
Did not examine/Unclear: Denotes studies in which (1) only one sex was studied, (2) sex interactions were not ruled out, (3) marginally significant sex differences were found, or (4) sex differences were found in measures not included in the Bold Underlining denotes studies that observed sex differences. Psychological and biological responses to stress, particularly early-life stress, are sexually dimorphic (for review see Bale and Epperson, 2015) . Men and women differ in the types of stressors that most impact depression risk (Chu et al., 2013) . Although women are more likely to develop a depressive disorder, men may be more susceptible to the immediate neurobiological effects of stress, including stress-related c-fos expression, enhanced fear conditioning, and increased hypothalamic-pituitary-adrenal axis response (for review see Altemus, 2006) . Work in animals has suggested neurobiological mechanisms for the observed sex difference in stress response. For example, male rats exposed to perinatal stress show a period in adolescence of increased neurogenesis, BDNF expression, and spatial learning that is reduced by adulthood, whereas female rats exhibit the opposite pattern of decreased neurogenesis in adolescence, followed by an increase in adulthood (Loi et al., 2014) . When examining three-way interactions among stress, sex, and genotype, researchers must remember that observed differences in subclinical traits, neuroimaging, and neuroanatomy may represent either risk mechanisms or protective compensatory mechanisms.
5-HTTLPR
The 5-HTTLPR polymorphism is associated with the largest body of research with regard to sex differences; a recent review of sex differences in 5-HTTLPR included 78 studies (Gressier et al., 2016) . The 5-HTTLPR polymorphism consists of a 16-repeat long variant and a 14-repeat short variant, which causes decreased SLC6A4 transcription (Lesch et al., 1996) . The long variant is further modified by a single nucleotide polymorphism, A/G SNP rs25531, with L(A) variants expressing normally and L(G) variants expressing similarly to the S allele (Wendland et al., 2006) . In this Mini-Review, we designate the S and L(G) alleles as low-expressing alleles.
Although 5-HTTLPR and gender may modulate depression risk, severity, and suicide risk independently of environmental stress (see Table I ), the depressogenic effect of the low-expressing alleles may be potentiated by stressful life events, particularly in early childhood (Caspi et al., 2003) . This finding has been supported by subsequent meta-analyses (Karg et al., 2011; Sharpley et al., 2014) , although others have yielded negative results (Munaf o et al., 2009; Risch et al., 2009) . The gene-environment interaction becomes stronger when taking sex into account, with a majority of studies showing that lowexpressing alleles interact with stress to confer risk more specifically in females (see Table I ).
Neuroimaging evidence supports the hypothesis that the 5-HTTLPR polymorphism differently influences hippocampal, amygdalar, and cortical structure in men and women in the context of early-life stress (see Fig. 1 ). However, although several studies have established a relationship between low-expressing alleles and amygdala hyperreactivity, no sex differences have been found because few studies have explicitly examined gene-sex interactions (see Table I ). Connections between genotype and personality traits provide a mechanism by which 5-HTTLPR may differentially interact with sex to alter preclinical risk factors independently of early-life stress exposure (Table I) .
The mechanistic basis of how 5-HTTLPR variation leads to biobehavioral sex differences is still unclear, but multiple lines of evidence illustrate sex-specific effects on serotonin metabolism. 5-HTTLPR genotype interacts with sex to modulate resting-state cerebral blood flow in the amygdala (El-Hage et al., 2013) as well as resting-state electroencephalography activity (Volf et al., 2015) . Depressed women but not men exhibit lower levels of serotonin transporter availability relative to their healthy counterparts (Staley et al., 2006) . The low-expressing allele is associated with lower 5-hydroxyindolacetic (5-HIAA) in males and higher 5-HIAA in females, indicative of differing rates of CNS serotonin turnover (Williams et al., 2003) . Women who are homozygous for lowexpressing alleles exhibit altered 5-HT1A receptor binding, which may indicate either a higher 5-HT1A receptor density or a lower level of serotonin with respect to highexpressing allele carriers, a difference not observed in men (Lothe et al., 2009) . Tryptophan depletion leads to increased impulsivity in men and increased caution and mood reduction in women and is particularly marked in women who are homozygous for either allele (Walderhaug et al., 2007) . The effect of 5-HTTPLR genotype on women is further underscored by another study showing tryptophan depletion-induced mood reductions in women who are homozygous for the low-expressing alleles, no change in women who are homozygous for the highexpressing allele, and intermediate effects in heterozygote women, depending on the presence of a family history of depression (Neumeister et al., 2002) .
Given the findings of gene-sex-environment interactions, another important mechanism may be the interaction of 5-HTTLPR genotype and stress. The lowexpressing alleles correlated with greater cortisol reactivity to stress in both a mixed group (Way and Taylor, 2010) and a group of girls (Gotlib et al., 2008) . Sex also interacts with the 5-HTTLPR polymorphism to predict cortisol awakening response, adrenocorticotropic hormone (ACTH) levels after dexamethasone administration (Wust et al., 2009 ), diurnal cortisol (Wankerl et al., 2010) , and cortisol response to stress (Jabbi et al., 2007) . A study of macaques showed a higher ACTH stress response only in females with a history of adversity (Barr et al., 2004) . Altogether, these data provide evidence that 5-HTTLPR confers depression risk through differential susceptibility to stress, with the low-expressing alleles associated with sensitivity to the environment and the high-expressing allele associated with immunity to environmental effects (Paaver et al., 2008; Nilsson et al., 2015) . The lowexpressing allele predicts increased stress generation in both males and females with low relational security and decreased stress generation with high relational security (Starr et al., 2013) . A similar differential susceptibility model has been shown to underlie the influence of other serotonin system genes in an additive multilocus score (Vrshek-Schallhorn et al., 2015) . These findings underscore the importance of additional research on the biological mechanisms of interactions among 5-HTTLPR genotype, sex, and environmental stress.
Mechanism: Sex Chromosomes
A systematic coverage of epigenetic sex differences is beyond the scope of this Mini-Review. In the current context, we highlight a special case of epigenetic modification, X-inactivation of the sex chromosome, the consequences of which are not currently well specified. The choice of which X-chromosome will be inactivated in a given cell is random, creating a mosaic of different cell populations (Migeon, 2007) . Furthermore, approximately 15% of genes escape inactivation, and an additional 10% show heterogeneous inactivation, creating differences in gene expression levels between males and females and variability among females (Carrel and Willard, 2005) . In addition, the sex-determining region Y (SRY), which is found only on the male Y-chromosome, plays a role in modulating autosomal gene expression (Wijchers et al., 2010) . Given the complexity of gene-sex interactions, it is difficult to conclude with certainty when Xinactivation is a primary factor. However, inheritance patterns in family studies have raised the possibility that sexlinked genes play a role in depression; maternal grandfather longevity was associated with mental health in a male group, although maternal mental health was not associated, suggestive of an X-linked recessive genetic basis (Vaillant et al., 2005) . Several X-linked genes have been associated with depression endophenotypes, including HTR2C, although its interactions with sex remain unclear (Avery and Vrshek-Schallhorn, 2016 ).
MAOA-LPR
MAOA is an X-linked gene that regulates monoamine neurotransmission by degrading serotonin, noradrenaline, and dopamine; MAOA knockout mice are characterized by higher levels of serotonin and noradrenaline and increased aggressive behavior (Cases et al., 1995) . In humans, the polymorphic region located upstream of the coding sequence has been widely studied with regard to conduct disorder, which co-occurs with depression and other affective disorders in both children and adults (Puig-Antich, 1982; Marriage et al., 1986; Zoccolillo, 1992) . The polymorphism consists of two, three, three and one-half, four, or five copies of a repeat sequence, with the rarer two, three, and five repeats exhibiting lower promoter activity (Sabol et al., 1998; Guo et al., 2008) .
Males carrying low-activity alleles (MAOA-L) are more likely to develop a conduct disorder and exhibit increased aggression and impulsivity, particularly in the presence of childhood maltreatment (see Table II ; for review see Byrd and Manuck, 2014) , whereas the highactivity allele (MAOA-H) has been associated with increased ventrolateral prefrontal activity (Cerasa et al., 2008a) and gray matter loss (Cerasa et al., 2008b ). In females, however, conduct disorder and aggression have been linked to the high-activity alleles (MAOA-H; Wakschlag et al., 2010; Aslund et al., 2011) . MAOA-H also confers risk for depression and anxiety disorders in women specifically (see Table II ). Other polymorphisms in MAOA, including 1460T, MAOA-CA, and 941T, have also shown sex differences in conferring risk for depression and anxiety (Tadic et al., 2003; Slopien et al., 2012) .
Studies on brain structure and activity have indicated subclinical sex differences that may explain the opposing findings in the clinical literature (Fig. 1) . Amygdala activity during emotional face matching increases with childhood stress in male MAOA-L carriers and decreases with childhood stress in male MAOA-H carriers, with the reverse occurring in females (Holz et al., 2016) . Amygdala volume, however, was not affected by MAOA genotype or an interaction effect between genotype and sex (Cerasa et al., 2011) . Increased hippocampal activity (Meyer-Lindenberg et al., 2006 ) and dysregulated ventromedial prefrontal cortex (Buckholtz et al., 2008) were observed in MAOA-L males but not females (see Fig. 1 ). Studies on personality provide minimal evidence for sex differences (see Table II ), with no sex differences seen in trait aggression, reactive aggression, or dorsal anterior cingulate cortex reactivity to social exclusion (Eisenberger et al., 2007; Kuepper et al., 2013) .
Just as with 5-HTTLPR, MAOA-LPR may exert its effects through sex-dependent differential susceptibility. Sex differences may be due to differential responses to stress or to sex-dependent methylation patterns, which are themselves also affected by stress. Sex interacts with MAOA genotype to influence both baseline cortisol and subjective stress (Jabbi et al., 2007) . Depressed females, particularly those who have experienced early-life stress, exhibit lower methylation at the MAOA locus Melas et al., 2013) . Another possible mechanism of sex difference is the SRY element found on the Y chromosome, which activates and regulates MAOA transcription (Wu et al., 2009) . A more thorough understanding of how sex-dependent methylation and sex-based gene dose effects contribute to the impact of risk polymorphisms may yield additional insight into biological mechanisms.
Mechanism: Hormones
There is a strong case to be made for the role of estrogen and other sex steroids as factors in mood and depression. The highest rates of depression onset in women correspond with major hormonal changes, peaking in puberty, in the postpartum period, and at the age of menopause onset (Joffe and Cohen, 1998) . Testosterone has been shown to have antidepressant and anxiolytic effects in both men and women (McHenry et al., 2014) , and changes in salivary testosterone over the course of a day correlate with depression and anxiety measures (Granger et al., 2003) . Hormones may also affect mood indirectly by altering gene expression, changing the rate of gene transcription, or regulating mRNA stability (Ing, 2005) . The expression of both serotonin transporter (McQueen et al., 1997) and MAOA (Gundlah et al., 2002 ) is regulated by estrogen. Exogenous hormone administration has also been shown to alter the functioning of the serotonergic system; female-to-male transsexuals undergoing androgen treatment have increased serotonin transporter binding, whereas male-to-female transsexuals undergoing antiandrogen and estrogen treatments have decreased serotonin transporter binding (Kranz et al., 2015) .
TPH
TPH is the rate-limiting enzyme in serotonin synthesis. The TPH2 isozyme is the predominant form in the brain, highly expressed in the serotonergic raphe nuclei (Bach-Mizrachi et al., 2005) ; however, the TPH1 isozyme is also highly expressed in the amygdala (Zill et al., 2007) . Both forms are regulated by both estrogen (Hiroi et al., 2006; Hiroi and Honda, 2013; Gutknecht et al., 2015) and testosterone (Goldstein et al., 1992) , and both have been linked to depression and related conditions in both men and women (see Table III ). The TPH A218C polymorphism is associated with depression in males only (Serretti et al., 2001) . Other alleles play a stronger role in conferring risk for depression and anxiety to women in the peripartum phase (Sun et al., 2004; Lin et al., 2009 ), suggestive of an intermediary role for hormones.
Variation in TPH2 has also been associated with depression and suicide in both men and women as well as with amygdala activity (see Table III ). TPH2 variations also exhibit gene-sex interactions, predicting depression (Shen et al., 2011) and panic disorder (Maron et al., 2007) in women but not in men. Adult male T carriers of the TPH2 G-703T polymorphism have a stronger overall startle response, whereas the effect is reversed in adult females; this finding in females achieves significance only after accounting for menstrual cycle phase, and no sex interaction effects were seen in children or older adults, suggestive of a modulatory role for hormones (Armbruster et al., 2010) .
Most studies have not addressed sex differences, but there is evidence from metabolic and animal studies to support the differences that have been found in both TPH1 and TPH2. The TPH1 218C (in depressed women, but not depressed men) allele is associated with decreased plasma tryptophan in women but not in men (Porter et al., 2008) . TPH2 knockout mice exhibit anxiety-and depression-like behaviors, with males showing increased impulsivity and aggression and females showing increased reactivity to aversive conditions (Gutknecht et al., 2015) .
CONCLUSIONS AND CONSIDERATIONS FOR
FUTURE RESEARCH By giving three examples of how sex modulates genotype to yield differing risk and expression of depression and related conditions, we hope to have made clear the importance of considering sex differences in the context of genetic variation. We expect that there are still many undiscovered gene-sex interactions because many of the genetic polymorphisms that have previously been associated with depression have not been explicitly studied with regard to sex differences. More research is required to clarify the mechanisms through which genes contribute differentially to depression in men and women, and we conclude by raising methodological considerations and guidelines for future research.
This Mini-Review of sex differences suggests several methodological considerations for future research on sex differences. To address them, we must re-evaluate how we conceptualize genetic risk, diagnostic categories, and sex itself. As we have shown, the same genotype can lead to different conditions in men and women, and alleles that confer risk to one sex may confer protection to the other; risk, therefore, cannot be directly attributed to a particular allele outside of the context of its effects on biological pathways and its interactions with the environment. We have also seen how similar underlying biological dysfunctions may give rise to different behavioral outputs in men and women. This raises the issue of how to group participants for experimental studies of gene-sex interactions, given that they may be heterogeneous with respect both to diagnosis and to genetic risk profile. Another consideration is how to conceptualize sex. Some sex differences, such as those stemming from X-inactivation, arise from the most simplistic, chromosome-based formulation of sex, whereas others, such as hormones, arise from factors that vary with sex. Although this Mini-Review focuses on the interplay of biological sex and genes, genetic effects might also be modulated by gender, self-identity, and cultural expectations.
It is essential that future research in the genetics of depression explicitly check for interactions with sex and sex-related factors known to be relevant. For example, because some sex differences are dependent on levels of cycling hormones, it is vital to incorporate the hormonal status of female participants. Otherwise, the effect of sexually asymmetric alleles may be diluted to the point of statistical insignificance or even bidirectionally cancel out. In addition, it is important to check for three-way interactions among environment, sex, and genotype. The sex differences relevant to depression and related conditions may be obscured by compensatory mechanisms in healthy individuals, given that sexual dimorphisms in the brain may in fact exist to prevent rather than cause sexually dimorphic behavior in the healthy brain (De Vries 2004) . It is possible that some sex differences emerge only in the context of pathology, such as in the case of early-life stress modulation of gene-sex interactions. Therefore, researchers must be careful in extrapolating sex differences or lack thereof in healthy individuals to patients.
Future studies of gene-sex differences may move beyond understanding the basis of genetic risk toward understanding the pathogenic mechanism of disease. Studies that consider multiple time points and longitudinal trajectories rather than cross-sectional grouping of participants are required to elucidate the role of sex differences and genetic risk in causal pathways for depression and emotional disorder. Such studies might incorporate intermediate measures such as subclinical manifestations of depression, stress response dysregulation, and personality traits to elucidate the mechanisms by which risk converts to overt psychopathology. Studies on groups of individuals who are biologically homogenous rather than symptomatically homogenous may help to isolate the distinct mechanisms of depression pathogenesis that create epidemiological differences between the sexes. Studies that cross traditional diagnostic boundaries may better capture the full range of behavioral output in men and women and better elucidate how sex differences in behavior and psychopathology emerge from similar underlying biology.
Finally, because the ultimate goal of research on depression is to treat individuals, it is vital to extend these considerations of gene-sex interactions to the domain of treatment. Given that men and women exhibit different pathways to pathology, it is reasonable to expect different pathways to recovery. Research has supported the existence of gender differences in the response to pharmacological treatment (Gorman, 2006) . Understanding the different mechanisms that contribute to psychopathology in men and women is essential for developing and targeting personalized interventions.
Although it is premature to define generalizable rules about these interactions or even to draw strong conclusions about the examples discussed, we may in the interim outline some central considerations that emerge from reviewing our current state of knowledge. We note that 1) there is a paucity of information on the impact of sex and gene interactions; 2) evidence from limited studies do support the idea that there are sex and gene interactions with clinically relevant outcomes; 3) these differences might be potentiated by environmental stressors; 4) these gene-sex and gene-sex-environment interactions must be tested explicitly; 5) adopting more nuanced conceptions of genetic risk, diagnostic categories, and sex itself will help to clarify these interactions; and 6) additional research using these methodological recommendations is essential for understanding underlying mechanisms. Although by necessity this Mini-Review has focused on depression and sex differences on the serotonergic system, we hope that it will facilitate a broader consideration of the topic because there are likely many more differences between sexes that are relevant for understanding the trajectory of mental disorders.
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